Prostate Cancer Vaccine | search
Click here to view Prostate Cancer Vaccine news from 60+ newspapers.
Bookmark or Share- What’s new in immunotherapy for prostate cancer?One of the earliest immunotherapies approved by the Food and Drug Administration (FDA) for the treatment of cancer was a vaccine called sipuleucel-T. It’s been used to treat metastatic prostate cancer since 2010.
- Immunotherapy for Prostate CancerImmunotherapy is the use of medicines to stimulate a person’s own immune system to recognize and destroy cancer cells more effectively. Certain types of immunotherapy can be used to treat prostate cancer. Sipuleucel-T (Provenge) is a cancer vaccine.
- Prostate Cancer Vaccines: What’s the Latest? - blog.dana-farber.orgResearchers are exploring a variety of vaccine approaches that are showing promise in prostate cancer, which has historically been a difficult malignancy to target with vaccines and other immunotherapies.
- Vaccines as treatments for prostate cancer - NatureFor over 30 years, growing interest has focused on the development of vaccines as treatments for prostate cancer, with the goal of using vaccines to activate immune cells capable of...
- Immunotherapy for Prostate Cancer - Johns Hopkins MedicineImmunotherapy for prostate cancer works by helping a patient’s own immune system fight back against cancer cells. One immune therapy that has been approved by the FDA is a vaccine called sipuleucel-T (Provenge), which spurs a patient’s immune system to attack prostate cancer cells.
More
